A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients
Not Applicable
Completed
- Conditions
- HIV Infections
- Registration Number
- NCT00002201
- Lead Sponsor
- Abbott
- Brief Summary
The purpose of this study is to see if it is safe and effective to give ritonavir plus nelfinavir to HIV-infected patients. This study will also see how ritonavir and nelfinavir are absorbed by the body and how they affect the level of HIV in the blood.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Johns Hopkins Hosp
🇺🇸Baltimore, Maryland, United States